Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mohammad Shawaqfeh
Liquid Chromatography–mass Spectrometric Assay for the Quantitation in Human Plasma of ABT-888, an Orally Available, Small Molecule Inhibitor of Poly(ADP-Ribose) Polymerase
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
Biochemistry
Clinical Biochemistry
Analytical Chemistry
Cell Biology
Medicine
Related publications
Liquid Chromatographic Determination of NSC 737664 (ABT-888: An Inhibitor of Poly(ADP-Ribose) Polymerase (PARP)) in Plasma and Urine in a Phase 0 Clinical Trial
Journal of Liquid Chromatography and Related Technologies
Biochemistry
Clinical Biochemistry
Analytical Chemistry
Pharmaceutical Science
Liquid Chromatography–mass Spectrometric Assay for Quantitation of the Short-Chain Fatty Acid, 2,2-Dimethylbutyrate (NSC 741804), in Rat Plasma
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
Biochemistry
Clinical Biochemistry
Analytical Chemistry
Cell Biology
Medicine
Liquid Chromatography–tandem Mass Spectrometric Assay for the Quantitation in Human Plasma of the Novel Indenoisoquinoline Topoisomerase I Inhibitors, NSC 743400 and NSC 725776
Journal of Pharmaceutical and Biomedical Analysis
Clinical Biochemistry
Drug Discovery
Analytical Chemistry
Spectroscopy
Pharmaceutical Science
Poly (ADP-ribose) Polymerase Inhibitor, an Effective Radiosensitizer in Lung and Pancreatic Cancers
Oncotarget
Oncology
Vasoactivity of AG014699, a Clinically Active Small Molecule Inhibitor of Poly(ADP-Ribose) Polymerase: A Contributory Factor to Chemopotentiation in Vivo?
Clinical Cancer Research
Cancer Research
Oncology
Proteomic Investigation of Phosphorylation Sites in Poly(ADP-Ribose) Polymerase-1 and Poly(ADP-Ribose) Glycohydrolase
Journal of Proteome Research
Biochemistry
Chemistry
Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes
Cancers
Cancer Research
Oncology
Targeting Poly(ADP-Ribose) Polymerase Activity for Cancer Therapy
Cellular and Molecular Life Sciences
Molecular Neuroscience
Molecular Medicine
Cell Biology
Molecular Biology
Pharmacology
Cellular
Characterization of Absorption, Metabolism, and Elimination of Niraparib, an Investigational Poly (ADP-Ribose) Polymerase Inhibitor, in Cancer Patients
Clinical Therapeutics
Pharmacology